Since it is well known that human BRAF-addicted CRCs are characterized by reduced responsiveness to chemotherapeutics [9–11], we evaluated the drug sensitivity of BRAF-mutated compared to BRAF-wild type (wt) human CRC cell lines. Here, BRAF is linked to colorectal carcinoma.